Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cachexia × Fecal Microbiota Transplantation × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Myelodysplastic Syndromes 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Hematologic Neoplasms 2 Carcinoma, Hepatocellular 2 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Non Small Cell Lung Cancer Metastatic 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hodgkin Disease 1 Graft vs Host Disease 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Cachexia 1 Acute Graft Versus Host Disease 1

Interventions

Megestrol Acetate 4 Mirtazapine 2 ostarine 1 nabiximols 1 clazakizumab 1 anamorelin 1 Sodium Chloride 1 Physical Therapy Modalities 1 Omacor 1 Olanzapine 1 Nutrition Assessment 1 Megestrol 1 Infliximab 1 Ibuprofen 1 Gemcitabine 1 Flurandrenolone 1 Fecal Microbiota Transplantation 1 Cyproheptadine 1 Clarithromycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07533227 2026-04-16

FMT-CACH

Changzhou No.2 People's Hospital

Phase 2 Not yet recruiting

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡